[1]刘 俊,严 婷,刘 红,等.2013~2019年广州某院消化系统恶性肿瘤流行病学分析[J].医学信息,2020,33(23):137-140.[doi:10.3969/j.issn.1006-1959.2020.23.040]
　LIU Jun,YAN Ting,LIU Hong,et al.Epidemiological Analysis of Malignant Tumors of the Digestive System in a Hospital in Guangzhou from 2013 to 2019[J].Medical Information,2020,33(23):137-140.[doi:10.3969/j.issn.1006-1959.2020.23.040]
点击复制

2013~2019年广州某院消化系统恶性肿瘤流行病学分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年23期
页码:
137-140
栏目:
调查分析
出版日期:
2020-12-01

文章信息/Info

Title:
Epidemiological Analysis of Malignant Tumors of the Digestive System in a Hospital in Guangzhou from 2013 to 2019
文章编号:
1006-1959（2020）23-0137-04
作者:
刘 俊; 严 婷; 刘 红; 等
（中山大学附属第六医院医政处1，临床营养科2，广东 广州 510655）
Author(s):
LIU Jun; YAN Ting; LIU Hong; et al
(Department of Medical Administration1,Department of Clinical Nutrition2,the Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou 510655,Guangdong,China)
关键词:
消化系统; 恶性肿瘤; 性别; 直肠癌; 胃癌
Keywords:
Digestive system; Malignant tumor; Gender; Rectal cancer; Gastric cancer
分类号:
R735
DOI:
10.3969/j.issn.1006-1959.2020.23.040
文献标志码:
A
摘要:
目的 分析广州某三甲医院2013~2019年收治的消化系统恶性肿瘤患者的流行病学特征，为开展消化系统恶性肿瘤的防治工作提供科学依据。方法 调取某院2013~2019年首次诊断为消化系统恶性肿瘤（C15-C26）的病案首页信息，分析不同性别、不同年份、不同年龄消化系统恶性肿瘤构成情况。结果 消化系统恶性肿瘤患者男性多于女性，男女比例为1.77∶1，尤其是食管癌（4.32∶1）和肝癌（4.03∶1），男女患者构成比较，差异有统计学意义（P＜0.05）；2013~2019年某院收治的消化系统恶性肿瘤病人呈逐年增长趋势，肿瘤前5位依次是直肠癌、结肠癌、胃癌、食管癌、肝癌；其中结直肠癌的构成比呈逐年上升趋势，胃癌的构成比先保持不变后呈下降趋势；食管癌和肝癌的构成比呈逐年下降趋势；发病年龄高峰主要集中在50~60岁（25.15%）和60~70岁（31.68%）。结论 消化系统恶性肿瘤发病具有性别、年龄、部位差异，应关注结直肠癌和胃癌及中老年人群，重视消化系统恶性肿瘤的三级预防，降低消化系统肿瘤的发病率和疾病负担。
Abstract:
Objective To analyze the epidemiological characteristics of digestive system malignant tumors from 2013 to 2019 in a tertiary hospital in Guangzhou, to provide scientific reference for tumor prevention and treatment.Methods Collecting information on the first page of medical records of a hospital diagnosed with malignant tumors of the digestive system (C15-C26) from 2013 to 2019, and analyze the composition of malignant tumors of the digestive system of different genders, years and ages.Results There were more males than females in patients with malignant tumors of the digestive system, with a male to female ratio of 1.77∶1, especially for esophageal cancer (4.32∶1) and liver cancer (4.03∶1). There was a statistically significant difference in the composition of male and female patients (P＜0.05); The number of patients with malignant tumors of the digestive system admitted to a hospital from 2013 to 2019 was increasing year by year. The top 5 tumors were rectal cancer, colon cancer, gastric cancer, esophageal cancer, and liver cancer. Among them, the proportion of colorectal cancer was increasing year by year, and gastric cancer composition ratio of esophageal cancer and liver cancer showed a downward trend year after year; the composition ratio of esophageal cancer and liver cancer was declining year by year; the peak age of onset was mainly concentrated in 50-60 years (25.15%) and 60-70 years (31.68%).Conclusion The incidence of malignant tumors of the digestive system has differences in gender, age, and location. We should pay attention to colorectal cancer, gastric cancer, and middle-aged and elderly people, and pay attention to the tertiary prevention of malignant tumors of the digestive system to reduce the incidence and burden of diseases of digestive system tumors.

参考文献/References:

[1]李宁,李亮,陈作森,等.2012-2017年潍坊市恶性肿瘤发病与死亡流行病特征及变化趋势分析[J].中华肿瘤防治杂志2019,26(12):821-826. [2]张梅烈,黄一峰,赵玉,等. 高密市2011-2015年消化系统恶性肿瘤流行病学分析[J].中国公共卫生管理 2018,34(2):230-232. [3]Ray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. [4]文国虹,王华东,冯冕,等.南充市三甲综合医院2010年-2018年恶性肿瘤住院患者分析[J].中国病案,2020,21(4):74-76. [5]郭艳芳,刘晋洪,黄宝珍,等.深圳市宝安区2006-2011年恶性肿瘤发病趋势分析[J].中华肿瘤防治杂志,2013,20(9):650-655. [6]王东进.高质医保与病有良医[J].中国医疗保险,2020(3):1-4. [7]兰震,迟卫军,付凌雨.某院2013年-2017年消化系统恶性肿瘤住院患者的疾病构成[J].中国病案2019,20(1):53-56. [8]周迪. 胆囊癌危险因素再探讨及幽门螺杆菌和雌激素促进胆道上皮异常增殖的研究[D].上海交通大学,2016. [9]汪建平.重视结直肠癌流行病学研究[J],中国实用外科杂志,2013,33(8):622-624. [10]邵红梅,冯瑞,朱红,等.中国人群结直肠癌危险因素的Meta分析[J].中国慢性病预防与控制,2014,22(2):174-177. [11]左婷婷,郑荣寿,曾红梅,等.中国食管癌发病状况与趋势分析[J].中华肿瘤杂志,2016(9):703-708. [12]王静雷,杨一兵,耿云霞,等.1990-2017年中国胃癌发病、患病及死亡状况趋势分析[J].中国慢性病预防与控制,2020,28(5):321-325. [13]张庆慧,刘晓波,李胜保,等.食管癌的发病现状及趋势分析[J].湖北医药学院学报,2019,38(2):192-196. [14]俞顺章.通过"预防为主"切断母婴传播促进我国乙型肝炎和肝癌发病率持续下降[J].中华流行病学杂志,2019(12):1650-1653. [15]张晓怡,沈毅,韩雅斌,等.桐乡市常见恶性肿瘤危险因素分析[J].浙江预防医学,2014,26(2):150-153. [16]梅越.丹江口市食管癌与胃癌危险因素的病例对照研究[D].武汉科技大学,2019. [17]曹光文.我国恶性肿瘤防治研究和实践需要技术、管理和观念的创新[J].中华流行病学杂志,2017,38(1):3-12. [18]曾伟,张晓丹.肿瘤三级预防的研究思路和方法[J].临床医学研究与实践,2016,1(9):81.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
　YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Medical Information,2018,31(23):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
　TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Medical Information,2022,35(23):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[3]张国锐,贾 林,赵 丹,等.老年维持血液透析患者恶性肿瘤发病的相关因素分析[J].医学信息,2022,35(10):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
　ZHANG Guo-rui,JIA Lin,ZHAO Dan,et al.Analysis of Related Factors of Malignant Tumor in Elderly Maintenance Hemodialysis Patients[J].Medical Information,2022,35(23):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
[4]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(23):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[5]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
　HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Medical Information,2019,32(23):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[6]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,32(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
　LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Medical Information,2019,32(23):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[7]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
　CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Medical Information,2019,32(23):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
[8]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,32(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
　DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Medical Information,2019,32(23):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[9]易亭伍,邓窈窕,宿向东.恶性肿瘤患者及家属信息需求现状的多中心研究[J].医学信息,2019,32(22):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
　YI Ting-wu,DENG Yao-tiao,SU Xiang-dong.Multi-center Study on the Status of Information Needs of Patients with Malignant Tumors and their Families[J].Medical Information,2019,32(23):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
[10]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Medical Information,2020,33(23):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]

更新日期/Last Update: 1900-01-01